What medications can cause tinnitus (ringing in the ears)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications That Cause Tinnitus (Ringing in the Ears)

Highest Risk Medications

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) are among the most common culprits for medication-induced tinnitus, with frequent use significantly increasing risk. 1, 2

NSAIDs and Aspirin

  • Tinnitus from NSAIDs is reversible and may signal high medication blood levels 1
  • Frequent NSAID use (4-5 days/week) increases tinnitus risk by 17%, and daily use (6-7 days/week) increases risk by 7% 2
  • High-dose aspirin commonly precipitates tinnitus, though low-dose aspirin (for cardiac protection) does not significantly elevate risk 2
  • Moderate-dose aspirin used 6-7 days/week increases tinnitus risk by 16% in women under age 60 2
  • Indomethacin is particularly associated with central nervous system effects including tinnitus, especially in older adults 1

Chemotherapy Agents

  • Platinum-based chemotherapy (cisplatin, carboplatin) causes the highest risk of permanent tinnitus among all medications 3, 4
  • Cisplatin causes permanent ototoxicity in 20-75% of patients and increases tinnitus risk 5.53-fold 3, 4
  • Carboplatin increases tinnitus risk 3.75-fold 4
  • No treatment can reverse established ototoxicity from cisplatin, making prevention and early detection critical 3

Aminoglycoside Antibiotics

  • Streptomycin, kanamycin, amikacin, and other aminoglycosides cause irreversible ototoxicity affecting the eighth cranial nerve 1, 5
  • Symptoms include tinnitus, vertigo, ataxia, nystagmus, and hearing loss 1
  • Ototoxic antibiotics increase tinnitus risk 2.81-fold 4
  • Risk increases when combined with other ototoxic drugs (amphotericin B, cephalosporins, ethacrynic acid, furosemide, vancomycin, cisplatin) 1

Macrolide Antibiotics

  • Azithromycin can cause hearing loss, deafness, and tinnitus 1
  • These effects are listed among general adverse effects including anaphylaxis and taste/smell perversion 1

Other Analgesics

  • Acetaminophen used 6-7 days/week increases tinnitus risk by 18% 2
  • The risk magnitude increases with frequency of use 2

Moderate Risk Medications

Antimalarial/Antirheumatic Drugs

  • Chloroquine can cause tinnitus as an adverse effect 1

Tuberculosis Medications

  • Streptomycin causes dose-dependent ototoxicity with tinnitus as an early warning sign 1
  • Dosage should be reduced immediately if headache, vomiting, vertigo, or tinnitus occur 1
  • Cycloserine causes central nervous system effects including vertigo, with risk highest at doses >500 mg/day 1

Cardiovascular Medications

  • ACE inhibitors can cause drug-induced rhinitis but are not prominently associated with tinnitus 1
  • Phosphodiesterase-5 inhibitors (erectile dysfunction medications) may cause drug-induced symptoms 1

Anticonvulsants (Paradoxically Used for Treatment)

  • While some anticonvulsants are used to treat tinnitus, they can also cause it in certain contexts 6

Critical Clinical Evaluation

When tinnitus develops during medication use, immediately obtain comprehensive audiometric testing covering 500-8000 Hz to detect accompanying hearing loss 3

Essential Workup

  • Pure tone audiometry is mandatory, as hearing loss frequently accompanies medication-induced tinnitus 3
  • Delaying audiometric testing can lead to permanent damage 3
  • Comprehensive otologic examination by the American Academy of Otolaryngology-Head and Neck Surgery standards 3

Warning Signs Requiring Urgent Evaluation

  • Severe anxiety or depression related to tinnitus 3
  • Progressive hearing loss 3
  • Unilateral symptoms (may indicate other pathology) 7

Management Algorithm

Step 1: Identify and Discontinue Offending Agent

  • Stop the causative medication immediately if medically feasible 1, 3
  • For NSAIDs: tinnitus is typically reversible upon discontinuation 1
  • For chemotherapy: tinnitus may be permanent even after stopping 3, 4

Step 2: Audiometric Assessment

  • Obtain baseline audiometry before starting known ototoxic medications when possible 3
  • Repeat testing if tinnitus develops 3

Step 3: Implement Evidence-Based Treatments

  • Cognitive behavioral therapy (CBT) provides the strongest evidence for improving quality of life in persistent tinnitus (moderate to high strength of evidence) 3, 7
  • Hearing aids are recommended for any degree of documented hearing loss (moderate strength of evidence) 3, 7
  • Wide-band sound therapy combined with CBT-based counseling shows the strongest evidence base 7

Step 4: Special Considerations

  • For chemotherapy patients: hearing aids and CBT remain beneficial even though ototoxicity cannot be reversed 3
  • Ensure autoinjectable epinephrine availability if patient has alpha-gal syndrome (relevant for certain biologics) 8

Common Pitfalls to Avoid

  • Never dismiss tinnitus as a minor side effect—it may signal dangerous medication levels or permanent damage 1, 3
  • Do not continue ototoxic antibiotics without monitoring when tinnitus develops 1
  • Avoid combining multiple ototoxic medications (aminoglycosides + loop diuretics + NSAIDs) 1
  • Do not delay audiometric testing, as this can miss the window for preventing permanent damage 3
  • Baseline tinnitus rates are high (47%) in older populations, so distinguish new-onset from pre-existing tinnitus 4

Medications With Lower/No Association

  • Low-dose aspirin (81 mg daily for cardiac protection) does not significantly elevate tinnitus risk 2
  • Trimethoprim-sulfamethoxazole lists tinnitus as a neurologic adverse effect but is not a primary cause 1
  • Most medications without direct ototoxic properties do not cause tinnitus 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medication-Induced Tinnitus Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drugs in the treatment of tinnitus.

Ciba Foundation symposium, 1981

Research

Tinnitus.

Lancet (London, England), 2013

Guideline

Medications Likely Causing Reactions in Alpha-Gal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.